论文部分内容阅读
目的探讨沙丁胺醇联合布地奈德雾化吸入治疗喘息性支气管炎的临床效果。方法共112例患儿,治疗组56例,对照组56例。治疗组沙丁胺醇0.02ml/(kg·次),布地奈德0.5mg/次,加生理盐水至2ml,雾化吸入。对照组常规应用氨溴索15mg/次,雾化吸入,静脉地塞米松0.3～0.5mg/(kg·次),一次滴入,疗程均为7d。结果治疗组总有率明显高于对照组,两者差异有统计学意义。两组3个月、6个月再发率比较有统计学意义。结论沙丁胺醇联合布地奈德雾化吸入治疗喘息性支气管炎疗效好,症状缓解快。
Objective To investigate the clinical effect of salbutamol combined with budesonide inhalation on asthmatic bronchitis. Methods A total of 112 children, treatment group 56 cases, control group 56 cases. The treatment group salbutamol 0.02ml / (kg · times), budesonide 0.5mg / times, plus normal saline to 2ml, inhalation. Control group routine use of ambroxol 15mg / times, inhalation, intravenous dexamethasone 0.3 ~ 0.5mg / (kg · times), a drop, treatment were 7d. Results The total rate of treatment group was significantly higher than the control group, the difference was statistically significant. Two groups of 3 months, 6 months recurrence rate was statistically significant. Conclusions Salbutamol combined with budesonide inhalation is effective in the treatment of asthmatic bronchitis and the symptoms are relieved quickly.